Azathioprine for prevention of postoperative recurrence in Crohn's disease

被引：8
|
作者：
Travis, S [1 ]
机构：
[1] John Radcliffe Hosp, Gastroenterol Unit, Oxford OX3 9DU, England
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2001年 / 13卷 / 11期
关键词：
Crohn's disease; surgery; therapy; thiopuriness;
D O I：
10.1097/00042737-200111000-00001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The clinical relapse rate after surgery for Crohn's disease in prospective studies is about 40% at 2 years in people who receive no postoperative prophylaxis. Thiopurines (azathioprine and 6-mercaptopurine) are likely to be the most effective pharmacotherapy for preventing postoperative relapse: about four patients need to be treated for 2 years to prevent one clinical relapse. The factors that help to identify patients at highest risk of relapse are discussed, along with the reasons for the choice of thiopurine, dose and duration of therapy. Other measures to reduce the relapse rate are addressed. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码：1277 / 1279
页数：3
相关论文
共 50 条
  • [31] A New Anastomotic Technique for Prevention of Postoperative Recurrence in Crohn's Disease
    Yamamoto, Takayuki
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (06) : 1169 - 1169
  • [32] A New Anastomotic Technique for Prevention of Postoperative Recurrence in Crohn’s Disease
    Takayuki Yamamoto
    [J]. Journal of Gastrointestinal Surgery, 2013, 17 : 1169 - 1169
  • [33] Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
    Colombel, JF
    Rutgeerts, P
    Malchow, H
    Jacyna, M
    Nielsen, OH
    Rask-Madsen, J
    Van Deventer, S
    Ferguson, A
    Desreumaux, P
    Forbes, A
    Geboes, K
    Melani, L
    Cohard, M
    [J]. GUT, 2001, 49 (01) : 42 - 46
  • [34] Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
    Buisson, Anthony
    Nancey, Stephane
    Manlay, Luc
    Rubin, David T.
    Hebuterne, Xavier
    Pariente, Benjamin
    Fumery, Mathurin
    Laharie, David
    Roblin, Xavier
    Bommelaer, Gilles
    Pereira, Bruno
    Peyrin-Biroulet, Laurent
    Vuitton, Lucine
    [J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2021, 9 (05) : 552 - 560
  • [35] Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: A controlled randomized trial
    D'Haens, Geert R.
    Vermeire, Severine
    Van Assche, Gert
    Noman, Maja
    Aerden, Isolde
    Van Olmew, Gust
    Rutgeerts, Paul
    [J]. GASTROENTEROLOGY, 2008, 135 (04) : 1123 - 1129
  • [36] Vedolizumab is effective in the prevention and treatment of postoperative recurrence in patients with Crohn's disease
    Kadleckova, B.
    Podmanicky, D.
    Lipovska, A.
    Zelinkova, Z.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I470 - I470
  • [37] Strategies for the Prevention of Postoperative Recurrence in Crohn's Disease: Results of a Decision Analysis
    Ananthakrishnan, Ashwin N.
    Hur, Chin
    Juillerat, Pascal
    Korzenik, Joshua R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (11): : 2009 - 2017
  • [38] Prevention and treatment of postoperative Crohn's disease recurrence: An update for a new decade
    Schwartz M.
    Regueiro M.
    [J]. Current Gastroenterology Reports, 2011, 13 (1) : 95 - 100
  • [39] State-of-the-art medical prevention of postoperative recurrence of Crohn's disease
    Sorrentino, Dario
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (07) : 413 - 422
  • [40] Prevention of Postoperative Recurrence of Crohn's Disease: What Does the Evidence Support?
    Moss, Alan C.
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (04) : 856 - 859
12345